Sigal Kremer-Tal, MD.

VP Scouting & Operations

Dr. Kremer-Tal joined RAD BioMed in December 2010. Sigal is responsible for the accelerator's screening process and deal flow management, working closely with RAD BioMed's portfolio companies and actively involved in day to day operations, R&D activities and strategic decisions.
Prior to joining RAD BioMed, Sigal was engaged in clinical research at Novartis US. Prior thereto, she worked at Mount Sinai School of Medicine, where she engaged in cancer and liver genetics research. Dr. Kremer-Tal has a medical degree from the Hebrew University and did her training in Internal Medicine at Rabin Medical Center.